Concepedia
Statistics
Publications
31
Citations
2.8K
H-Index
21
Active since
2000
Affiliations
Sichuan University(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
West China Second University Hospital of Sichuan University
West China Medical Center of Sichuan University
West China Hospital of Sichuan University
Mei Wu is an author at Sichuan University specializing in medicine, pharmacotherapy, and immunology.
Publications per year
2000–2024
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
B Charbonnel, Avraham Karasik, Ji Liu et al. · Diabetes Care · 2006 · 790 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women<sup>1</sup>
Richard P. Tonino, Pierre J. Meunier, Ronald Emkey et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 337 citations
Medicine, Pharmacotherapy, Bone Augmentation +16
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
Itamar Raz, Yu Chen, Mei Wu et al. · Current Medical Research and Opinion · 2008 · 262 citations
Medicine, Pharmacology, Pharmacotherapy +16
Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes
Russell Scott, Mei Wu, Miguel A. Sánchez et al. · International Journal of Clinical Practice · 2006 · 260 citations
Pharmacy, Pharmacology, Pharmacotherapy +11
Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes
M Hanefeld, Gary Herman, Mei Wu et al. · Current Medical Research and Opinion · 2007 · 160 citations
Pharmacy, Pharmacology, Pharmacotherapy +13
1–5 of 31